From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD

VANCOUVER, British Columbia, March 9 (Bernama-GLOBE NEWSWIRE) — The world’s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend their successes to optimistically forge a path to overcome one’s biggest challenge – their health.

Going public with his own story, Wilson, who was diagnosed with Facioscapulohumeral muscular dystrophy type 2 (FSHD2) at age 32, announced he has committed $100 million and created a new venture, Solve FSHD, with the objective of finding a cure for FSHD by 2027, targeting the underlying genetic cause or improving muscle function and growth.

http://mrem.bernama.com/viewsm.php?idm=42602

administrator

Related Articles